Login | Users Online: 3076  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us
Year : 2014  |  Volume : 15  |  Issue : 3  |  Page : 74-76

Cardioprotective effects of ghrelin in heart failure: From gut to heart

1 Department of Physiology, JNMC, Wardha, Maharashtra, India
2 The School of Health and Related Research, The University of Sheffield, United Kingdom
3 Vice Chancellor, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India

Correspondence Address:
Mahalaqua Nazli Khatib
Department of Physiology, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1995-705X.144792

Rights and Permissions

Chronic heart failure (CHF) is a major cause of morbidity and mortality. Cardioprotective effects of ghrelin, especially in its acylated form have been demonstrated in heart failure (HF) models and exploratory human clinical studies. Hence, it has been proposed for the treatment of HF. However, the underlying mechanism of its protective effects against HF remains unclear. Future researches are needed to evaluate the efficacy of Ghrelin as a new biomarker and prognostic tool and for exploring its therapeutic potential in patients suffering from CHF.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded156    
    Comments [Add]    
    Cited by others 22    

Recommend this journal